Protective Effects of Erdosteine on Doxorubicin-induced Hepatotoxicity in Rats

Archives of Medical Research

Volumn 38, Issue 4, 2007, Pages 380-385

  Yagmurca, Murat ^a   Bas, Orhan ^a   Mollaoglu, Hakan ^a   Sahin, Onder ^a   Nacar, Ahmet ^b   Karaman, Ozcan ^a   Songur, Ahmet ^a  

^a AFYON KOCATEPE UNIVERSITY   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

Author keywords

Antioxidant; Doxorubicin; Erdosteine; Hepatotoxicity

Indexed keywords

CARBONYL DERIVATIVE; CATALASE; DOXORUBICIN; ERDOSTEINE; MALONALDEHYDE; NITRIC OXIDE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEGENERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; HISTOLOGY; HISTOPATHOLOGY; LIVER BLOOD VESSEL; LIVER CELL; LIVER CONGESTION; LIVER HEMORRHAGE; LIVER INJURY; LIVER NECROSIS; LIVER PROTECTION; LIVER SINUSOID; LIVER TOXICITY; MICROSCOPY; NONHUMAN; PROTEIN CARBONYLATION; RAT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIOXIDANTS; DOXORUBICIN; LIPID PEROXIDATION; LIVER; LIVER DISEASES; MALE; RATS; RATS, SPRAGUE-DAWLEY; THIOGLYCOLATES; THIOPHENES;

EID: 34047116980     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2007.01.007     Document Type: Article

References (31)

1. Singal P.K., Deally C.M., and Weinberg L.E. Subcellular effects of adriamycin in the heart: a concise review. J Mol Cell Cardiol 99 (1987) 817-828
2. Fadillioglu E., Erdogan H., Sogut S., and Kuku I. Protective effects of erdosteine against doxorubicin-induced cardiomyopathy in rats. J Appl Toxicol 23 (2003) 71-74
3. Yagmurca M., Erdogan H., Iraz M., Songur A., Ucar M., and Fadillioglu E. Caffeic acid phenethyl ester as a protective agent against doxorubicin nephrotoxicity in rats. Clin Chim Acta 348 (2004) 27-34
4. Saad S.Y., Najjar T.A., and Al-Rikabi A.C. The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats. Pharmacol Res 43 (2001) 211-218
5. Karaman A., Fadillioglu E., Turkmen E., Tas E., and Yilmaz Z. Protective effects of leflunomide against ischemia reperfusion injury of the rat liver. Pediatr Surg Int 22 (2006) 428-434
6. Abd El-Aziz M.A., Othman A.I., Amer M., and El-Missiry M.A. Potential protective role of angiotensin-converting enzyme inhibitors captopril and enalapril against adriamycin-induced acute cardiac and hepatic toxicity in rats. J Appl Toxicol 21 (2001) 469-473
7. Fadillioglu E., Oztas E., Erdogan H., Yagmurca M., Sogut S., Ucar M., et al. Protective effects of caffeic acid phenethyl ester on doxorubicin-induced cardiotoxicity in rats. J Appl Toxicol 24 (2004) 47-52
8. Braga P.C., Dal Sasso M., and Zuccotti T. Assessment of the antioxidant activity of the SH metabolite I of erdosteine on human neutrophil oxidative bursts. Arzneimittelforschung 50 (2000) 739-746
9. Inglesi M., Nicola M., Fregnan G.B., Bradamante S., and Pagani G. Synthesis and free radical scavenging properties of the enantiomers of erdosteine. Farmaco 40 (1994) 703-708
10. Sogut S., Ozyurt H., Armutcu F., Kart L., Iraz M., Akyol O., et al. Erdosteine prevents bleomycin-induced pulmonary fibrosis in rats. Eur J Pharmacol 494 (2004) 213-220
11. Yagmurca M., Fadillioglu E., Erdogan H., Ucar M., Sogut S., and Irmak M.K. Erdosteine prevents doxorubicin-induced cardio-toxicity in rats. Pharmacol Res 48 (2003) 377-382
12. Venditti P., Balestrieri M., De Leo T., and Di Meo S. Free radical involvement in doxorubucin-induced electrophysiological alterations in rat papillary muscle fibres. Cardiovasc Res 38 (1998) 695-702
13. Ozyurt H., Yildirim Z., Kotuk M., Yilmaz H.R., Yagmurca M., Iraz M., et al. Cisplatin-induced acute renal failure is ameliorated by erdosteine in a dose dependent manner. J Appl Toxicol 24 (2004) 269-275
14. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the folin-phenol reagent. J Biol Chem 183 (1951) 265-275
15. Wasowicz W., Neve S., and Peretz A. Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. Clin Chem 39 (1993) 2522-2526
16. Sahin S., Sogut S., Ozyurt H., Uz E., Ilhan A., and Akyol O. Tissue xanthine oxidase activity and nitric oxide levels after spinal cord ischemia/reperfusion injury in rabbits: comparison of caffeic acid phenethyl ester (CAPE) and methylprednisolone. Neurosci Res Commun 31 (2002) 111-121
17. Cortas N.K., and Wakid N.W. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 36 (1990) 1440-1443
18. Levine R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A.G., et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186 (1990) 464-478
19. Sun Y., Oberley L.W., and Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 34 (1988) 497-500
20. Durak I., Yurtarslani Z., Canbolat O., and Akyol O. A methodological approach to superoxide dismutase (SOD) activity assay based on inhibition of nitroblue tetrazolium (NBT) reduction. Clin Chim Acta 214 (1993) 103-104
21. Aebi H. Catalase. In: Bergmeyer H.U. (Ed). Methods of Enzymatic Analysis (1974), Academic Press, New York, NY and London, UK 673-677
22. Songur A., Akpolat N., Kus I., Ozen O.A., Zararsiz I., and Sarsilmaz M. The effects of the inhaled formaldehyde during the early postnatal period in the hippocampus of rats: a morphological and immunohistochemical study. Neurosci Res Commun 33 (2003) 168-178
23. Sahin O., Sulak O., Yavuz Y., Uz E., Eren I., Ramazan Yilmaz H., Malas M.A., Altuntas I., and Songur A. Lithium-induced lung toxicity in rats: the effect of caffeic acid phenethyl ester (CAPE). Pathology 38 (2006) 58-62
24. Minotti G., Mancuso C., Frustaci A., Mordente A., Santini S.A., Calafiore A.M., et al. Paradoxicol inhibition of cardiac lipid peroxidation in cancer patients treated with doxorubicin. Pharmacologic and molecular reappraisal of anthracycline cardiotoxicity. J Clin Invest 98 (1996) 650-661
25. Esterbauer H., and Cheeseman K.H. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. In: Packer L., and Glazer A.N. (Eds). Methods in Enzymology, Vol. 186 (1990), Academic Press, San Diego, CA 407-421
26. Kalender Y., Yel M., and Kalender S. Doxorubicin hepatotoxicity and hepatic free radical metabolism in rats. The effects of vitamin E and catechin. Toxicology 209 (2005) 39-45
27. Deepa P.R., and Varalakshmi P. Protective effect of low molecular weight heparin on oxidative injury and cellular abnormalities in adriamycin-induced cardiac and hepatic toxicity. Chem Biol Interact 146 (2003) 201-210
28. Yildirim Z., Sogut S., Odaci E., Iraz M., Ozyurt H., Kotuk M., et al. Oral erdosteine administration attenuates cisplatin induced renal tubular damage in rats. Pharmacol Res 47 (2003) 149-156
29. Nussler A.K., Di Silvio M., Liu Z.Z., Geller D.A., Freeswick P., Dorko K., et al. Further characterization and comparison of inducible nitric oxide synthase in mouse, rat, and human hepatocytes. Hepatology 21 (1995) 1552-1560
30. Laszlo F., Whittle B.J., Evans S.M., and Moncada S. Association of microvascular leakage with induction of nitric oxide synthase: effects of nitric oxide synthase inhibitors in various organs. Eur J Pharmacol 283 (1995) 47-53
31. Fadillioglu E., Yilmaz H.R., Erdogan H., and Sogut S. The activities of tissue xanthine oxidase and adenosine deaminase and the levels of hydroxyproline and nitric oxide in rat hearts subjected to doxorubicin: protective effect of erdosteine. Toxicology 191 (2003) 153-158